Heart Failure: Discrepancy Between NYHA Functional Classification, Serum NT-pro Brain Natriuretic Peptide and Ejection Fraction
Author:
Publisher
Modestum Publishing Ltd
Subject
General Medicine
Link
https://www.ejgm.co.uk/download/heart-failure-discrepancy-between-nyha-functional-classification-serum-nt-pro-brain-natriuretic-7028.pdf
Reference18 articles.
1. Richards AM, Nicholls MG, Yandle TG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-9
2. Anand IS, Fisher LD, Chiang Y-T, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003;10:1278-83
3. Gopal DJ, Iqbal MN, Maisel A. Updating the role of natriuretic peptide levels in cardiovascular disease. Postgrad Med 2011;123:102-13
4. Linssen GC, Rienstra M, Jaarsma T, et al. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011;13:1111-20
5. Masugata H, Senda S, Murao K, et al. Association between echocardiographic parameters and brain natriuretic peptide levels in treated hypertensive patients. Clin Exp Hypertens 2011;33:187-91
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients;ESC Heart Failure;2023-09-30
2. Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction – A report from FAR NHL prospective registry;PLOS ONE;2019-03-26
3. Identification, Associated Factors, and Prognosis of Symptom Clusters in Taiwanese Patients With Heart Failure;Journal of Nursing Research;2018-02
4. Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review;American Journal of Cardiovascular Drugs;2017-10-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3